#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liver transplant rejection Penile cancer B-cell small lymphocytic lymphoma recurrent Paget's disease of the vulva Desmoid tumour Synovial sarcoma recurrent Neuroendocrine carcinoma metastatic Neurodermatitis Malignant neoplasm of choroid Neoplasm Corneal neovascularisation Heritable pulmonary arterial hypertension Rosai-Dorfman syndrome Immune-mediated renal disorder Acute myeloid leukaemia refractory More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma – Trials in Disease Optic glioma – Treatment Chondrosarcoma metastatic – Basic Information Cytokine release syndrome – Trials in Disease Osteosarcoma recurrent – Basic Information Usher’s syndrome – Basic Information Angiosarcoma metastatic – Trials in Disease Pleomorphic leiomyosarcoma – Life with Disease Pemphigoid – Treatment Methylmalonic acidaemia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betamethasone Dipropionate ALFENTANIL HYDROCHLORIDE Orismilast Fexofenadine Avibactam Sodium Epirubicin Cldn6 Car-T Dexamethasone Inclisiran GSK4524101A Neob Infigratinib Nesolicaftor Famotidine Human Coagulation Factor Vii Levothyroxine Sodium Caba-201 Xenon NVG-2089 UDONITRECTAG More therapies…

    Learn about Your Condition

    Endocarditis enterococcal Anal squamous cell carcinoma Albuminuria Encephalitis autoimmune Dent's disease Polycythaemia vera Incontinence Schizophrenia Breast angiosarcoma Neuromyopathy Chronic kidney disease Atopic keratoconjunctivitis Papulopustular rosacea Menopause Primary hyperaldosteronism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study of ipilimumab and nivolumab to observe immune system changes in patients with unresectable stage III or IV melanoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant melanoma stage III
    • Malignant melanoma stage IV
    Investigated Drugs:
    • Ipilimumab
    The Netherlands

  • Evaluating the use of technetium (99mTc) galactosyl serum albumin to predict complications in patients undergoing surgery for liver tumors

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hepatic cancer
    Denmark

  • A study to evaluate the effect of allogeneic faecal microbiota on the core symptoms of autism spectrum disorder in children

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Allogeneic Faecal Microbiota
    Czechia

  • A study to compare using a half dose of iomeprol versus a standard dose of iomeprol for imaging lung tumors with spectral CT scans.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Iomeprol
    Spain

  • A study to evaluate if atorvastatin prevents gallstones in patients undergoing bariatric surgery

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Atorvastatin
    The Netherlands

  • A study to evaluate if hydrocortisone helps reduce symptoms of post-traumatic stress disorder in patients after exposure to a traumatic event.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Hydrocortisone
    The Netherlands
Previous Page
1 … 732 733 734 735 736 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!